Table 1. Patients characteristics.
| Treatment | Response in C | Age (yrs) | Sex | Paraprotein type | Serum beta2 microglobulin (mg/l) | Serum creatinine (µmol/l) | ||||
| A | B | C | A | B | C | |||||
| Intensive | Remission | 62 | M | GLO | 3.1 | 2.4 | 2.1 | 117 | 107 | 92 |
| Intensive | Remission | 66 | M | GKU | 3.8 | 2.1 | 2.2 | 92 | 95 | 102 |
| Intensive | Remission | 52 | F | GK0 | 3.5 | 2.1 | 1.8 | 78 | 75 | 75 |
| Intensive | Remission | 54 | F | NS | 1.0 | 2.4 | 2.3 | 43 | 63 | 84 |
| Intensive | Remission | 58 | F | KU0 | 1.3 | 1.9 | 1.1 | 45 | 51 | 63 |
| Intensive | Remission | 52 | M | AK0 | 2.7 | 1.9 | 1.6 | 106 | 84 | 103 |
| Intensive | Remission | 51 | F | DLU | 7.9 | 1.7 | 1.5 | 112 | 54 | 47 |
| Intensive | Remission | 57 | F | ALU | 2.7 | 1.8 | 1.9 | 84 | 76 | 85 |
| Intensive | Remission | 54 | M | GLU | 17.9 | 2.8 | 1.9 | 237 | 77 | 74 |
| Intensive | Relapse | 57 | F | KUS | 7.9 | 4.4 | 2.4 | 115 | 59 | 106 |
| Intensive | Relapse | 53 | M | GLU | 8.8 | 2.6 | 3.5 | 122 | 114 | 124 |
| Intensive | Relapse | 58 | M | GKU | 3.7 | 3.0 | 2.6 | 95 | 75 | 111 |
| Intensive | Relapse | 53 | M | GK0 | 3.3 | 2.8 | 2.3 | 79 | 83 | 119 |
| Intensive | Relapse | 58 | M | GKU | 3.1 | 2.4 | 2.1 | 86 | 87 | 88 |
| Intensive | Relapse | 46 | M | AKU | 1.4 | 2.9 | 4.1 | 65 | 109 | 120 |
| Intensive | Relapse | 61 | M | AKU | 3.2 | 3.3 | 2.9 | 98 | 102 | 111 |
| Intensive | Relapse | 52 | M | AKU | 1.8 | 2.4 | 2.1 | 62 | 82 | 81 |
| Intensive | Relapse | 52 | F | ALO | 3.3 | 3.0 | 1.8 | 75 | 113 | 77 |
| Non Int. | Remission | 80 | F | GLO | 3.8 | 4.0 | 4.0 | 57 | 69 | 75 |
| Non Int. | Remission | 71 | M | KUS | 3.7 | 3.7 | 4.7 | 103 | 164 | 120 |
| Non Int. | Remission | 74 | M | ALU | 7.2 | 2.3 | 2.1 | 116 | 77 | 88 |
| Non Int. | Remission | 76 | M | GKU | 7.3 | 3.0 | 2.9 | 133 | 94 | 119 |
| Non Int. | Relapse | 69 | M | DLU | 5.2 | 5.0 | 7.2 | 154 | 153 | 187 |
| Non Int. | Relapse | 74 | M | GKU | 6.7 | 3.0 | 4.3 | 135 | 133 | 137 |
| Non Int. | Relapse | 67 | M | GLU | 3.6 | 2.0 | 2.4 | 122 | 114 | 97 |
| Non Int. | Relapse | 73 | F | KUS | 4.4 | 3.1 | 3.8 | 118 | 61 | 89 |
| Non Int. | Relapse | 78 | F | ALO | 5.9 | 4.6 | 4.4 | 83 | 86 | 76 |
| Non Int. | Relapse | 74 | F | AKU | 11.2 | 3.3 | 10.7 | 165 | 102 | 141 |
| Non Int. | Relapse | 75 | F | GLU | 3.6 | 5.5 | 4.3 | 68 | 184 | 156 |
| Non Int. | Relapse | 71 | M | GKU | 3.1 | 3.8 | 3.2 | 78 | 75 | 85 |
| Non Int. | Relapse | 70 | F | GKO | 4.8 | 2.0 | 5.6 | 57 | 61 | 82 |
| Non Int. | Relapse | 68 | M | ALU | 5.7 | 2.8 | 3.7 | 232 | 145 | 154 |
Footnotes table 1. Serum reference ranges:- beta2 microglobulin 0.5–4.0 mg/l; serum creatinine 45–110 µmol/l (0.5 to 1.2 mg/dl). Paraprotein types detected by immunofixation of serum and urine: GLO IgG lambda, no flc in urine; GKU IgG kappa, flc in urine; NS non secretory, no Ig detected in blood or urine; KUO kappa flc only detected in urine but not serum; AKU IgA kappa, kappa flc in urine; ALO IgA lambda, no flc in urine; KUS kappa flc only detected in serum and urine; ALU IgA lambda, flc in urine; DLU IgD lambda, flc in urine.